3405:TSEKuraray Co., Ltd. Analysis
Data as of 2026-03-14 - not real-time
₩50,900.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
T&L Co., Ltd. trades at roughly KRW 50,900, which sits well above its DCF‑derived fair value of about KRW 37,240, indicating a potential overvaluation despite a forward P/E of 8.63 that is markedly lower than the industry average of 26.18. The company delivers solid profitability with an operating margin near 30% and a healthy dividend yield of 2.95% supported by a modest payout ratio of 13.8% and low debt‑to‑equity of 0.18, suggesting dividend sustainability. However, revenue has contracted by 16.5% year‑over‑year and the RSI of 48 and a bearish MACD signal point to neutral to slightly negative momentum, while volatility remains high at 61.8% and beta is modest at 0.66.
Liquidity appears improving as volume trends upward, but the stock faces a support level around KRW 44,600 and a resistance near KRW 57,700, framing a tight trading range. Investors should weigh the attractive dividend and low leverage against the revenue decline and over‑price relative to intrinsic estimates when forming a position.
Liquidity appears improving as volume trends upward, but the stock faces a support level around KRW 44,600 and a resistance near KRW 57,700, framing a tight trading range. Investors should weigh the attractive dividend and low leverage against the revenue decline and over‑price relative to intrinsic estimates when forming a position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above DCF fair value
- Bearish MACD and neutral RSI
- Increasing volume supporting short‑term stability
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustained dividend yield and low leverage
- Continued revenue contraction
- Valuation gap between market price and intrinsic value
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable cash generation and dividend sustainability
- Low debt and defensive healthcare exposure
- Potential upside if revenue turnaround occurs and price aligns with fair value
Key Metrics & Analysis
Financial Health
Revenue Growth-16.50%
Profit Margin24.69%
P/E Ratio8.6
ROE24.18%
ROA16.57%
Debt/Equity0.18
Op. Cash Flow₩42.3B
Free Cash Flow₩15.5B
Industry P/E26.2
Technical Analysis
TrendNeutral
RSI48.4
Support₩44,600.00
Resistance₩57,700.00
MA 20₩52,785.00
MA 50₩50,072.00
MA 200₩52,953.50
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value₩37,240.13
Target Price₩80,000.00
Upside/Downside57.17%
GradeOvervalued
TypeValue
Dividend Yield2.95%
Risk Assessment
Beta0.66
Volatility61.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.